GlaxoSmithKline Consumer Healthcare Pakistan Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was PKR 6,688.013 million compared to PKR 4,900.326 million a year ago. Operating income was PKR 908.935 million compared to PKR 564.972 million a year ago. Net income was PKR 663.718 million compared to PKR 382.937 million a year ago. Basic earnings per share from continuing operations was PKR 5.67 compared to PKR 3.27 a year ago. For the half year, sales was PKR 11,922.841 million compared to PKR 9,208.381 million a year ago. Operating income was PKR 1,805.794 million compared to PKR 991.258 million a year ago. Net income was PKR 1,278.728 million compared to PKR 683.598 million a year ago. Basic earnings per share from continuing operations was PKR 10.92 compared to PKR 5.84 a year ago.